Form 4: Bausch Health GC Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Bausch Health Companies Inc.'s EVP and General Counsel, Seana Carson, reported the sale of common shares totaling 13,370 units under a pre-arranged 10b5-1 trading plan, alongside tax-related share withholding.
Summary
- Seana Carson, Executive Vice President and General Counsel of Bausch Health Companies Inc. (BHC), reported transactions involving the company's common shares.
- On September 5, 2025, 51,337 common shares were withheld to satisfy tax obligations upon the vesting of Restricted Share Units, at a price of $7.35 per share.
- Following this withholding, Carson beneficially owned 512,955 common shares.
- On September 8, 2025, Carson sold 13,370 common shares in the open market at a price of $7.31 per share.
- This sale was executed pursuant to a Rule 10b5-1 plan adopted by Carson on May 7, 2025.
- After both transactions, Carson's direct beneficial ownership stands at 499,585 common shares.
Sentiment
Score: 5
Explanation: The filing reports routine insider transactions, including tax-related share withholding and a pre-planned sale under a 10b5-1 plan. These are generally neutral events that do not reflect new positive or negative information about the company's operations or prospects.
Positives
- The vesting of Restricted Share Units (RSUs) for the EVP, General Counsel, indicates the realization of previously granted equity compensation.
Negatives
- The disposition of 13,370 common shares by a key executive, even if pre-planned, reduces their direct ownership stake in the company.
Future Outlook
The filing indicates a pre-arranged plan for future share sales through the adoption of a Rule 10b5-1 plan on May 7, 2025, suggesting a structured approach to executive liquidity rather than a reaction to immediate market conditions.
Industry Context
This is a routine insider transaction report (Form 4) and does not provide specific insights into broader industry trends or competitive landscape. It reflects an executive's personal financial planning.
Stakeholder Impact
- Shareholders: The sale by a key executive, while pre-planned, slightly reduces insider ownership. However, the routine nature of the transaction under a 10b5-1 plan typically minimizes concerns about management's confidence in the company's future.
- Employees: The vesting of RSUs and subsequent tax withholding are part of standard executive compensation practices.
Key Dates
| Date | Description |
|---|---|
| 05/07/2025 | Date Reporting Person adopted the Rule 10b5-1 plan for the sale of common stock. |
| 09/05/2025 | Date of transaction where common shares were withheld for tax obligations upon RSU vesting. |
| 09/08/2025 | Date of transaction where common shares were sold in the open market pursuant to a Rule 10b5-1 plan. |
| 09/08/2025 | Signature date of the reporting person's attorney-in-fact for the filing. |
Keywords
Bausch Health Companies, BHC, Insider Trading, Form 4, Seana Carson, 10b5-1 Plan, Share Sale, Restricted Share Units, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.